Ronald D. Gunn
President at Kaleo, Inc.
Profile
Ronald D.
Gunn is currently the President at Kaleo, Inc. Previously, he held the position of Chief Operating Officer & Executive Vice President at Insmed, Inc. from 1999 to 2008.
He also worked as a Clinical Affairs Officer at Leiras from 1994 to 1996.
Additionally, he served as a Principal at A.H.
Robins Co., Inc. and as a Manager-Clinical Operations at Whitby Research, Inc. Mr. Gunn obtained a graduate degree and an MBA from Virginia Commonwealth University.
Ronald D. Gunn active positions
Companies | Position | Start |
---|---|---|
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | President | - |
Former positions of Ronald D. Gunn
Companies | Position | End |
---|---|---|
INSMED INCORPORATED | Chief Operating Officer | 11/01/2008 |
Leiras
Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Corporate Officer/Principal | - |
Whitby Research, Inc. | Corporate Officer/Principal | - |
A.H. Robins Co., Inc. | Corporate Officer/Principal | - |
Training of Ronald D. Gunn
Virginia Commonwealth University | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
INSMED INCORPORATED | Health Technology |
Private companies | 4 |
---|---|
Kaleo, Inc.
Kaleo, Inc. Pharmaceuticals: MajorHealth Technology Kaleo, Inc. develops drug/device combination products. Its products empower patients to gain freedom from their medical condition. The firm's capabilities include drug development, device development, regulatory and clinical, manufacturing, commercialization and data generation. The company was founded by Eric S. Edwards and Evan T. Edwards in 2005 and is headquartered in Richmond, VA. | Health Technology |
Leiras
Leiras Pharmaceuticals: OtherHealth Technology Part of Bayer AG, Leiras is a Finnish company that specializes in medicinal chemicals and botanical products. The company is located in Finland. Leiras was acquired by Bayer Schering Pharma AG on July 01, 1996 for $262.11 million. | Health Technology |
A.H. Robins Co., Inc. | Distribution Services |
Whitby Research, Inc. |
- Stock Market
- Insiders
- Ronald D. Gunn